$OSK
OSHKOSH CORP

2023 Q4 Form 10-Q Financial Statement

#000095017023055497 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $2.467B $2.510B
YoY Change 11.94% 21.44%
Cost Of Revenue $2.012B $2.042B
YoY Change 6.56% 14.19%
Gross Profit $454.4M $468.1M
YoY Change 44.25% 67.96%
Gross Profit Margin 18.42% 18.65%
Selling, General & Admin $224.3M $201.6M
YoY Change 40.72% 21.23%
% of Gross Profit 49.36% 43.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $55.30M $26.30M
YoY Change 101.82% 24.64%
% of Gross Profit 12.17% 5.62%
Operating Expenses $239.0M $211.6M
YoY Change 47.17% 23.45%
Operating Profit $215.4M $256.5M
YoY Change 41.15% 139.05%
Interest Expense -$20.80M -$17.70M
YoY Change 118.95% 62.39%
% of Operating Profit -9.66% -6.9%
Other Income/Expense, Net $600.0K $2.600M
YoY Change -101.88% -138.24%
Pretax Income $195.2M $241.4M
YoY Change 85.02% 169.42%
Income Tax $44.20M $55.30M
% Of Pretax Income 22.64% 22.91%
Net Earnings $150.8M $183.7M
YoY Change 100.8% 209.78%
Net Earnings / Revenue 6.11% 7.32%
Basic Earnings Per Share
Diluted Earnings Per Share $2.28 $2.79
COMMON SHARES
Basic Shares Outstanding 65.41M 65.30M
Diluted Shares Outstanding 65.95M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.4M $106.1M
YoY Change -84.44% -77.65%
Cash & Equivalents $125.4M $106.1M
Short-Term Investments
Other Short-Term Assets $93.60M $80.70M
YoY Change 3.2% -18.57%
Inventory $2.132B $2.021B
Prepaid Expenses
Receivables $2.088B $2.268B
Other Receivables $42.20M $15.60M
Total Short-Term Assets $4.481B $4.491B
YoY Change -1.13% 9.08%
LONG-TERM ASSETS
Property, Plant & Equipment $1.070B $954.8M
YoY Change 29.45% 36.22%
Goodwill $1.416B $1.506B
YoY Change 35.93% 46.66%
Intangibles $830.2M $762.4M
YoY Change 81.66% 63.89%
Long-Term Investments $34.50M
YoY Change -19.58%
Other Assets $1.332B $323.2M
YoY Change 52.84% -41.77%
Total Long-Term Assets $4.648B $4.364B
YoY Change 45.4% 53.27%
TOTAL ASSETS
Total Short-Term Assets $4.481B $4.491B
Total Long-Term Assets $4.648B $4.364B
Total Assets $9.129B $8.855B
YoY Change 18.12% 27.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.215B $1.092B
YoY Change 7.57% 7.06%
Accrued Expenses $242.5M $214.2M
YoY Change 102.93% 62.27%
Deferred Revenue $706.9M $664.0M
YoY Change 1.46% -4.99%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $175.0M $505.0M
YoY Change 1704.12% 5272.34%
Total Short-Term Liabilities $3.090B $3.090B
YoY Change 27.22% 35.96%
LONG-TERM LIABILITIES
Long-Term Debt $597.5M $597.5M
YoY Change 0.42% 0.45%
Other Long-Term Liabilities $1.710B $507.8M
YoY Change 12.52% 3.82%
Total Long-Term Liabilities $2.308B $1.105B
YoY Change 9.12% 1.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.090B $3.090B
Total Long-Term Liabilities $2.308B $1.105B
Total Liabilities $5.424B $4.196B
YoY Change 19.38% 24.99%
SHAREHOLDERS EQUITY
Retained Earnings $3.806B $3.682B
YoY Change 14.81% 17.95%
Common Stock $823.7M $827.6M
YoY Change 2.11% 2.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $852.2M $856.3M
YoY Change 1.01% 0.91%
Treasury Stock Shares
Shareholders Equity $3.705B $3.543B
YoY Change
Total Liabilities & Shareholders Equity $9.129B $8.855B
YoY Change 18.12% 27.15%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $150.8M $183.7M
YoY Change 100.8% 209.78%
Depreciation, Depletion And Amortization $55.30M $26.30M
YoY Change 101.82% 24.64%
Cash From Operating Activities $479.6M $166.6M
YoY Change 3.59% 3.35%
INVESTING ACTIVITIES
Capital Expenditures $97.30M $98.20M
YoY Change -185.43% -292.93%
Acquisitions
YoY Change
Other Investing Activities $2.800M -$797.5M
YoY Change -36.36% 99587.5%
Cash From Investing Activities -$94.50M -$895.7M
YoY Change -13.7% 1632.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -367.9M 480.4M
YoY Change 1008.13% -1919.7%
NET CHANGE
Cash From Operating Activities 479.6M 166.6M
Cash From Investing Activities -94.50M -895.7M
Cash From Financing Activities -367.9M 480.4M
Net Change In Cash 17.20M -248.7M
YoY Change -94.63% -399.28%
FREE CASH FLOW
Cash From Operating Activities $479.6M $166.6M
Capital Expenditures $97.30M $98.20M
Free Cash Flow $382.3M $68.40M
YoY Change -33.73% -67.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000775158
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-31371
dei Entity Registrant Name
EntityRegistrantName
Oshkosh Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WI
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-0520270
dei Entity Address Address Line1
EntityAddressAddressLine1
1917 Four Wheel Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Oshkosh
dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
54902
dei City Area Code
CityAreaCode
920
dei Local Phone Number
LocalPhoneNumber
502-3400
dei Security12b Title
Security12bTitle
Common Stock $0.01 par value
dei Trading Symbol
TradingSymbol
OSK
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65413503
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2509900000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2066700000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7191100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6078400000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2041800000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1778100000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5964700000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5339000000
CY2023Q3 us-gaap Gross Profit
GrossProfit
468100000
CY2022Q3 us-gaap Gross Profit
GrossProfit
288600000
us-gaap Gross Profit
GrossProfit
1226400000
us-gaap Gross Profit
GrossProfit
739400000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
201600000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
166300000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
586100000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
503400000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8600000
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2100000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2100000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
211600000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
171400000
us-gaap Operating Expenses
OperatingExpenses
604200000
us-gaap Operating Expenses
OperatingExpenses
514100000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
256500000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
117200000
us-gaap Operating Income Loss
OperatingIncomeLoss
622200000
us-gaap Operating Income Loss
OperatingIncomeLoss
225300000
CY2023Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
19600000
CY2022Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
13400000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
46300000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
39200000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1900000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2500000
us-gaap Investment Income Interest
InvestmentIncomeInterest
13300000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4800000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2600000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6800000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20800000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
241400000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
99500000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
602400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
170100000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55300000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68400000
CY2023Q3 osk Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
186100000
CY2022Q3 osk Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
67300000
osk Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
456600000
osk Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
101700000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2400000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-400000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9400000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2900000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
183700000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
66900000
us-gaap Profit Loss
ProfitLoss
447200000
us-gaap Profit Loss
ProfitLoss
98800000
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.81
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.02
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.84
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.5
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.79
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.02
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
6.8
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.49
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.41
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.23
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.11
CY2023Q3 us-gaap Profit Loss
ProfitLoss
183700000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
66900000
us-gaap Profit Loss
ProfitLoss
447200000
us-gaap Profit Loss
ProfitLoss
98800000
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
400000
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-400000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1200000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1200000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22400000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-36200000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-7500000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-76600000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
3900000
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-5800000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
8900000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-11000000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-26700000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17600000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-64400000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
157000000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36900000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
429600000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34400000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106100000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
805900000
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1550200000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1162000000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
717500000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
586300000
CY2023Q3 us-gaap Inventory Net
InventoryNet
2020600000
CY2022Q4 us-gaap Inventory Net
InventoryNet
1865600000
CY2023Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
15600000
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
21600000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
80700000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
90700000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
4490700000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4532100000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
954800000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
826200000
CY2023Q3 us-gaap Goodwill
Goodwill
1505800000
CY2022Q4 us-gaap Goodwill
Goodwill
1042000000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
762400000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
457000000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
195100000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
134800000
CY2023Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
623100000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
415800000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
323200000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
321100000
CY2023Q3 us-gaap Assets
Assets
8855100000
CY2022Q4 us-gaap Assets
Assets
7729000000
CY2023Q3 us-gaap Debt Current
DebtCurrent
505000000
CY2022Q4 us-gaap Debt Current
DebtCurrent
9700000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1092200000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1129000000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
664000000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
696700000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
214200000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
119500000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
178300000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
100300000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
436500000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
373400000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3090200000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2428600000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
597500000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
595000000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1088700000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1020500000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27600000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
507800000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
499200000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75101465
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75101465
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
700000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
700000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
826900000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
806000000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3681900000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3315000000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-109900000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-92300000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9719772
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9629317
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
856300000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
843700000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3543300000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3185700000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8855100000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7729000000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3396800000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
183700000
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-200000
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
400000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22400000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-3900000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.41
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26700000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
6200000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10100000
CY2023Q3 osk Adjustments Related To Tax Withholding Shares Tendered For Taxes On Share Based Compensation
AdjustmentsRelatedToTaxWithholdingSharesTenderedForTaxesOnShareBasedCompensation
100000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3543300000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3012000000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
66900000
CY2022Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
100000
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-400000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-36200000
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
5800000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
24200000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
500000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8800000
CY2022Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
100000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3033900000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3185700000
us-gaap Profit Loss
ProfitLoss
447200000
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-400000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1200000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-7500000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-8900000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.23
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
80300000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22600000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
9000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25700000
osk Adjustments Related To Tax Withholding Shares Tendered For Taxes On Share Based Compensation
AdjustmentsRelatedToTaxWithholdingSharesTenderedForTaxesOnShareBasedCompensation
3900000
us-gaap Stockholders Equity Other
StockholdersEquityOther
-100000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3543300000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3204300000
us-gaap Profit Loss
ProfitLoss
98800000
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
300000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1200000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-76600000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
11000000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.11
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
73100000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
155000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2800000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22300000
osk Adjustments Related To Tax Withholding Shares Tendered For Taxes On Share Based Compensation
AdjustmentsRelatedToTaxWithholdingSharesTenderedForTaxesOnShareBasedCompensation
1700000
us-gaap Stockholders Equity Other
StockholdersEquityOther
100000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3033900000
us-gaap Profit Loss
ProfitLoss
447200000
us-gaap Profit Loss
ProfitLoss
98800000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104600000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80200000
us-gaap Share Based Compensation
ShareBasedCompensation
25700000
us-gaap Share Based Compensation
ShareBasedCompensation
22300000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-5300000
osk Deferred Income Tax Expense Benefit Continuing And Discontinued Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuedOperations
-61500000
osk Deferred Income Tax Expense Benefit Continuing And Discontinued Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuedOperations
24500000
osk Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
-500000
osk Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
1900000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1400000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-12700000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4600000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8200000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2100000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9500000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
405300000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
111600000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
120000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
138300000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
228000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
160300000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
995800000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19500000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
32600000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-100000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
11100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1191100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190900000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1008500000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10400000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
513200000
us-gaap Repayments Of Debt
RepaymentsOfDebt
15500000
us-gaap Repayments Of Debt
RepaymentsOfDebt
225000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22600000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
155000000
us-gaap Payments Of Dividends
PaymentsOfDividends
80300000
us-gaap Payments Of Dividends
PaymentsOfDividends
73100000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5600000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9100000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
371300000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-451800000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-16500000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-699800000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-520900000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
805900000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
995700000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106100000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
474800000
us-gaap Interest Paid Net
InterestPaidNet
36700000
us-gaap Interest Paid Net
InterestPaidNet
35200000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
125400000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
207500000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
2800000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
1300000
us-gaap Operating Lease Payments
OperatingLeasePayments
40700000
us-gaap Operating Lease Payments
OperatingLeasePayments
37100000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24700000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6000000
us-gaap Contribution Of Property
ContributionOfProperty
25400000
us-gaap Contribution Of Property
ContributionOfProperty
26600000
osk Schedule Of Changes Within Defense Segment Due To Contract Adjustments Table Textblock
ScheduleOfChangesWithinDefenseSegmentDueToContractAdjustmentsTableTextblock
<p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:10pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Net contract adjustments impacted the Company’s results as follows (in millions, except per share amounts):</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:34.291%;"></td> <td style="width:1.639%;"></td> <td style="width:1%;"></td> <td style="width:12.79%;"></td> <td style="width:1%;"></td> <td style="width:1.639%;"></td> <td style="width:1%;"></td> <td style="width:12.79%;"></td> <td style="width:1%;"></td> <td style="width:1.639%;"></td> <td style="width:1%;"></td> <td style="width:12.79%;"></td> <td style="width:1%;"></td> <td style="width:1.639%;"></td> <td style="width:1%;"></td> <td style="width:12.79%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:9pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Three Months Ended<br/>September 30,</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Nine Months Ended<br/>September 30,</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Net sales</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.2</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">13.2</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">8.5</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">29.7</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:9pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Operating income</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.5</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">14.2</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">23.6</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">38.2</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:9pt;"> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Net income</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">1.9</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">10.9</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">18.1</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">29.2</span></p></td> <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:9pt;"> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Diluted earnings per share</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">0.03</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">0.17</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">0.28</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">0.44</span></p></td> <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0;font-size:9.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:9.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">)</span></p></td> </tr> </table>
CY2023Q3 osk Increase Decrease In Net Sales Due To Margin Rate Adjustments
IncreaseDecreaseInNetSalesDueToMarginRateAdjustments
2200000
CY2022Q3 osk Increase Decrease In Net Sales Due To Margin Rate Adjustments
IncreaseDecreaseInNetSalesDueToMarginRateAdjustments
-13200000
osk Increase Decrease In Net Sales Due To Margin Rate Adjustments
IncreaseDecreaseInNetSalesDueToMarginRateAdjustments
-8500000
osk Increase Decrease In Net Sales Due To Margin Rate Adjustments
IncreaseDecreaseInNetSalesDueToMarginRateAdjustments
-29700000
CY2023Q3 osk Increase Decrease In Operating Income Due To Margin Rate Adjustments
IncreaseDecreaseInOperatingIncomeDueToMarginRateAdjustments
2500000
CY2022Q3 osk Increase Decrease In Operating Income Due To Margin Rate Adjustments
IncreaseDecreaseInOperatingIncomeDueToMarginRateAdjustments
-14200000
osk Increase Decrease In Operating Income Due To Margin Rate Adjustments
IncreaseDecreaseInOperatingIncomeDueToMarginRateAdjustments
-23600000
osk Increase Decrease In Operating Income Due To Margin Rate Adjustments
IncreaseDecreaseInOperatingIncomeDueToMarginRateAdjustments
-38200000
CY2023Q3 osk Increase Decrease In Net Income Due To Margin Rate Adjustments
IncreaseDecreaseInNetIncomeDueToMarginRateAdjustments
1900000
CY2022Q3 osk Increase Decrease In Net Income Due To Margin Rate Adjustments
IncreaseDecreaseInNetIncomeDueToMarginRateAdjustments
-10900000
osk Increase Decrease In Net Income Due To Margin Rate Adjustments
IncreaseDecreaseInNetIncomeDueToMarginRateAdjustments
-18100000
osk Increase Decrease In Net Income Due To Margin Rate Adjustments
IncreaseDecreaseInNetIncomeDueToMarginRateAdjustments
-29200000
CY2023Q3 osk Increase Decrease In Earnings Per Share Due To Margin Rate Adjustments In Dollar Per Share
IncreaseDecreaseInEarningsPerShareDueToMarginRateAdjustmentsInDollarPerShare
0.03
CY2022Q3 osk Increase Decrease In Earnings Per Share Due To Margin Rate Adjustments In Dollar Per Share
IncreaseDecreaseInEarningsPerShareDueToMarginRateAdjustmentsInDollarPerShare
-0.17
osk Increase Decrease In Earnings Per Share Due To Margin Rate Adjustments In Dollar Per Share
IncreaseDecreaseInEarningsPerShareDueToMarginRateAdjustmentsInDollarPerShare
-0.28
osk Increase Decrease In Earnings Per Share Due To Margin Rate Adjustments In Dollar Per Share
IncreaseDecreaseInEarningsPerShareDueToMarginRateAdjustmentsInDollarPerShare
-0.44
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2509900000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2066700000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7191100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6078400000
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
664000000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
696700000
CY2023Q3 osk Contract With Customer Other Current Liability
ContractWithCustomerOtherCurrentLiability
90400000
CY2022Q4 osk Contract With Customer Other Current Liability
ContractWithCustomerOtherCurrentLiability
77400000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1088700000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1020500000
CY2023Q3 osk Contract With Customer Other Liability Noncurrent
ContractWithCustomerOtherLiabilityNoncurrent
69000000.0
CY2022Q4 osk Contract With Customer Other Liability Noncurrent
ContractWithCustomerOtherLiabilityNoncurrent
66800000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1912100000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1861400000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
130900000
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
125500000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
478500000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
320700000
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
76100000
CY2021Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
66900000
us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
27700000
us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
21600000
osk Product Warranty Amortization
ProductWarrantyAmortization
-19800000
osk Product Warranty Amortization
ProductWarrantyAmortization
-16100000
us-gaap Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
ExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-900000
CY2023Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
84000000.0
CY2022Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
71500000
CY2023Q3 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
29000000.0
CY2022Q4 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
26800000
CY2023Q3 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
55000000.0
CY2022Q4 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
49300000
CY2023Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
84000000
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
76100000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10690000000
CY2023Q3 osk Transaction Price Allocated To Performance Obligations To Be Satisfied During Current Fiscal Year
TransactionPriceAllocatedToPerformanceObligationsToBeSatisfiedDuringCurrentFiscalYear
846300000
CY2023Q3 osk Transaction Price Allocate To Performance Obligations Expected To Be Satisfied During The Subsequent Fiscal Year
TransactionPriceAllocateToPerformanceObligationsExpectedToBeSatisfiedDuringTheSubsequentFiscalYear
2890000000
CY2023Q3 osk Transaction Price Allocated To Performance Obligations Expected To Be Satisfied Beyond Current Fiscal Year
TransactionPriceAllocatedToPerformanceObligationsExpectedToBeSatisfiedBeyondCurrentFiscalYear
6950000000
CY2022Q4 us-gaap Government Contract Receivable
GovernmentContractReceivable
135300000
CY2023Q3 osk Other Trade Receivables
OtherTradeReceivables
1310000000
CY2022Q4 osk Other Trade Receivables
OtherTradeReceivables
979500000
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
8800000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
7300000
CY2023Q3 osk Notes Receivable
NotesReceivable
14900000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2779780
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10700000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
9400000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8600000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26500000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
22800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21300000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
17800000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55300000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32200000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.324
CY2023Q3 osk Income Tax Expense Benefit Tax Credit Discrete Items
IncomeTaxExpenseBenefitTaxCreditDiscreteItems
-1000000
CY2022Q3 osk Income Tax Expense Benefit Tax Credit Discrete Items
IncomeTaxExpenseBenefitTaxCreditDiscreteItems
900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145800000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68400000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.402
osk Income Tax Expense Benefit Tax Credit Discrete Items
IncomeTaxExpenseBenefitTaxCreditDiscreteItems
3200000
osk Income Tax Expense Benefit Tax Credit Discrete Items
IncomeTaxExpenseBenefitTaxCreditDiscreteItems
17800000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
18100000
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
91800000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
98800000
CY2023Q3 osk Unrecognized Tax Benefits That Would Impact Net Income
UnrecognizedTaxBenefitsThatWouldImpactNetIncome
50900000
osk Unrecognized Tax Benefits Income Tax Penalties And Interest Expense Income
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseIncome
1800000
osk Unrecognized Tax Benefits Income Tax Penalties And Interest Expense Income
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseIncome
1800000
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
6500000
CY2023Q3 us-gaap Other Receivables
OtherReceivables
90100000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
53300000
CY2023Q3 osk Receivables Gross
ReceivablesGross
1577200000
CY2022Q4 osk Receivables Gross
ReceivablesGross
1175400000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8000000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6700000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65342227
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65375424
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65363125
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65790599
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
603093
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
396396
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
449459
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
437911
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65945320
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65771820
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65812584
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66228510
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
227255
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67116
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
129151
CY2023Q3 us-gaap Government Contract Receivable
GovernmentContractReceivable
153400000
CY2023Q3 osk Receivables Net
ReceivablesNet
1569200000
CY2022Q4 osk Receivables Net
ReceivablesNet
1168700000
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1550200000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1162000000
CY2023Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
19000000
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
6700000
CY2023Q3 osk Receivables Net
ReceivablesNet
1569200000
CY2022Q4 osk Receivables Net
ReceivablesNet
1168700000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7200000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6400000
CY2023Q3 osk Allowance For Doubtful Accounts Receivable Acquisition Of Business
AllowanceForDoubtfulAccountsReceivableAcquisitionOfBusiness
1800000
CY2023Q3 osk Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
-200000
CY2022Q3 osk Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
700000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
800000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
400000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8000000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6700000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6700000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4200000
osk Allowance For Doubtful Accounts Receivable Acquisition Of Business
AllowanceForDoubtfulAccountsReceivableAcquisitionOfBusiness
1800000
osk Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
400000
osk Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
2900000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
900000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
400000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8000000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6700000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
51900000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
49400000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1227100000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1140600000
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
434500000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
383100000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
359000000.0
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
341900000
CY2023Q3 us-gaap Inventory Net
InventoryNet
2020600000
CY2022Q4 us-gaap Inventory Net
InventoryNet
1865600000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2016600000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1804400000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1061800000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
978200000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
954800000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
826200000
CY2023Q3 us-gaap Depreciation
Depreciation
26300000
CY2022Q3 us-gaap Depreciation
Depreciation
21100000
us-gaap Depreciation
Depreciation
75400000
us-gaap Depreciation
Depreciation
63100000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
601900000
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4400000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
597500000
CY2023Q3 us-gaap Debt Current
DebtCurrent
505000000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
600000000
CY2022Q4 us-gaap Goodwill
Goodwill
1042000000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-6000000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
469800000
CY2023Q3 us-gaap Goodwill
Goodwill
1505800000
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
2607300000
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1101500000
CY2023Q3 us-gaap Goodwill
Goodwill
1505800000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
2145800000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1103800000
CY2022Q4 us-gaap Goodwill
Goodwill
1042000000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P12Y2M12D
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1080000000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
729900000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
350100000
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
412300000
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
412300000
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1492300000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
729900000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
762400000
CY2022 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P14Y2M12D
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
790400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
720800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
69600000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
387400000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
387400000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1177800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
720800000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
457000000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
12800000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
51900000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
51900000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
51900000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5000000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
595000000
CY2022Q4 us-gaap Debt Current
DebtCurrent
9700000
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
14300000
CY2023Q3 osk Debt Instrument Leverage Ratio
DebtInstrumentLeverageRatio
0.0375
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
58800000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
65700000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
41600000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
38900000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
37300000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
43900000
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-1400000
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
1900000
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-100000
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-500000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-500000
us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
4900000
us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
200000
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
66000000.0
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
62300000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.5pt;font-family:Calibri;justify-content:flex-start;min-width:3.333%;">15.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Contingencies</span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Personal Injury Actions and Other</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> - Product and general liability claims are made against the Company from time to time in the ordinary course of business. The Company is generall</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">y self-insured for future claims up to $</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> million per claim. A reserve is maintained for the estimated costs of such claims. At </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">September 30, 2023 and December 31, 2022, the estimated net liabilities for product and general liability claims totaled </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">45.9</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">41.2</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">, respectively. There is inherent uncertainty as to the eventual resolution of unsettled claims. Management, however, believes that any losses in excess of established reserves will not have a material effect on the Company’s financial condition, results of operations or cash flows.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Market Risks</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> - The Company was contingently liable under bid, performance and specialty bonds totaling </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.42</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">2.04</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> at September 30, 2023 and December 31, 2022, respectively. Open standby letters of credit issued by the Company’s banks in favor of third parties totaled </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">16.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">$</span><span style="font-size:10.5pt;font-family:'Calibri',sans-serif;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">18.8</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> at September 30, 2023 and December 31, 2022, respectively.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Other Matters</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> - The Company is subject to environmental matters and legal proceedings and claims, including patent, antitrust, product liability, warranty and state dealership regulation compliance proceedings, that arise in the ordinary course of business. Although the final results of such matters and claims cannot be predicted with certainty, management believes that the ultimate resolution will not have a material effect on the Company’s financial condition, results of operations or cash flows. Actual results could vary, among other things, due to the uncertainties involved in litigation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Major contracts for military systems are performed over extended periods of time and are subject to changes in scope of work and delivery schedules. Pricing negotiations on changes and settlement of claims often extend over prolonged periods of time. The Company’s ultimate profitability on such contracts may depend on the eventual outcome of an equitable settlement of contractual issues with the Company’s customers.</span></p>
CY2019Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
4109419
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
7890581
CY2022Q2 osk Increased Number Of Shares Of Common Stock Authorized For Buyback
IncreasedNumberOfSharesOfCommonStockAuthorizedForBuyback
12000000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
265795
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22600000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1508467
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
155000000
CY2023Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
11284882
CY2023Q3 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
4700000
CY2023Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
2600000
CY2023Q3 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1900000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3800000
CY2022Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
12700000
CY2022Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1600000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2509900000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2066700000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7191100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6078400000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
256500000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
117200000
us-gaap Operating Income Loss
OperatingIncomeLoss
622200000
us-gaap Operating Income Loss
OperatingIncomeLoss
225300000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17700000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10900000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-33000000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-34400000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2600000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6800000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20800000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
241400000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
99500000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
602400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
170100000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2509900000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2066700000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7191100000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6078400000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-055497-index-headers.html Edgar Link pending
0000950170-23-055497-index.html Edgar Link pending
0000950170-23-055497.txt Edgar Link pending
0000950170-23-055497-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
osk-20230930.htm Edgar Link pending
osk-20230930.xsd Edgar Link pending
osk-ex31_1.htm Edgar Link pending
osk-ex31_2.htm Edgar Link pending
osk-ex32_1.htm Edgar Link pending
osk-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
osk-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
osk-20230930_def.xml Edgar Link unprocessable
osk-20230930_lab.xml Edgar Link unprocessable
osk-20230930_pre.xml Edgar Link unprocessable
osk-20230930_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending